LIPOMED
LIVE

Serial Number

79392576

Owner

LGC Limited

Attorney

Matthew Frisbee

Filing Date

Jan 12, 2024

Add to watchlist:

No watchlists yet
View on USPTO

LIPOMED Trademark

Serial Number: 79392576 • Registration: 8081491

LIPOMED is a trademark filed by LGC Limited on January 12, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

LGC Limited (27 trademarks)

Queens Road

Entity Type: 99

Trademark Details

Filing Date

January 12, 2024

Registration Date

December 30, 2025

Published for Opposition

November 11, 2025

Goods & Services

Chemicals used in industry, science, agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; chemicals and chemical products, namely, chemical reagents, assays, buffer and standard solutions used in analytical chemistry, analytes, multi-analytes and multi-analyte mixtures, for use in research; chemical reagents for use with chemicals and agrochemicals, other than for medical or veterinary purposes; substances for analytical and biochemical science, genetic measurements, chemical diagnostics, forensic analysis, DNA testing and analytical molecular biology, namely, chemical reagents, research assays, and chemical substances for use in scientific research, other than for medical or veterinary purposes in the nature of analytes, multi-analytes and multi-analyte mixtures; diagnostic assay preparations for scientific, industrial and research purposes; kits comprising assays and chemical reagents for industrial and scientific research purposes; all the aforesaid goods being reference standard materials

Pharmaceutical, veterinary, and medical preparations, namely chemical reagents, medical diagnostic assays for testing of body fluids, tissue samples, keratinized samples, hard tissue samples, and analytes, multi-analytes and multi-analyte mixtures in the nature of diagnostic substances for medical use for pharmaceutical, veterinary and medical use; clinical diagnostic reagents for pharmaceutical, veterinary and medical use; clinical diagnostic reagent kits comprised of chemical reagents for medical use, medical diagnostic, assays for testing of body fluids, tissue samples, keratinized samples, hard tissue samples, and, analytes, multi-analytes and multi-analyte mixtures in the nature of diagnostic substances for medical use for genetic diagnosis; diagnostic assay kits comprised of diagnostic agents, preparations and substances for medical diagnostic use; Substances, namely, chemical reagents for medical use, medical diagnostic, assays for testing of body fluids, tissue samples, keratinized samples, hard tissue samples, and, analytes, multi-analytes and multi-analyte mixtures in the nature of diagnostic substances for medical use, for forensic diagnostics; all the aforesaid goods being reference standard materials for use in medical, clinical, and veterinary settings

Scientific research; Quality control for others; chemical analysis; forensic analysis in the nature of research services in the field of forensic science, namely, analysis, detection and isolation of biological or chemical substances in forensic samples; biological research; testing services of the goods and services of others to determine conformity with certification and quality standards; testing of chemicals; information, advisory and consultancy services relating to all of the aforesaid; all the aforesaid relating to reference standard materials services

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
May 7, 2026 ADCH
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 30, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 30, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 30, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 14, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 10, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 10, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 10, 2025 ERFR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 6, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 6, 2025 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Oct 6, 2025 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 6, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 6, 2025 REAP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 12, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 27, 2025 OPNR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 7, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 7, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 7, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 7, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 7, 2025 REAP
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 10, 2025 GNFN
FINAL REFUSAL E-MAILED
Apr 10, 2025 GNFR
FINAL REFUSAL WRITTEN
Apr 10, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 25, 2025 TROA
REFUSAL PROCESSED BY IB
Sep 14, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 26, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 26, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 20, 2024 RFCR
NON-FINAL ACTION WRITTEN
Aug 19, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 8, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 5, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 1, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 28, 2024 REPR